In vitro assessment of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis using highly purified elementary bodies.

The Gen-Probe APTIMA Combo 2 assay has previously been reported to have a high sensitivity. The end point of this assay was evaluated using highly purified chlamydial elementary bodies (EBs). The performance of the APTIMA Combo 2 assay was compared with a commercially available PCR kit, AMPLICOR Chlamydia trachomatis. The number of inclusions of C. trachomatis at the end point of the APTIMA Combo 2 assay was 0.005 inclusion-forming units (i.f.u.) ml(-1), which was equivalent to 0.008 EBs per assay. The end point of the AMPLICOR kit was 5 i.f.u. ml(-1) (equivalent to 0.5 EB per assay). The efficacy of the AMPLICOR C. trachomatis assay was inhibited by phosphate or Fe2+ ion, while these had no effect on the APTIMA Combo 2 assay. In conclusion, the APTIMA Combo 2 assay appears to have a greater sensitivity than the AMPLICOR C. trachomatis assay for detection of C. trachomatis, while demonstrating few problems with inhibitory substances such as phosphate and Fe2+ ion.

[1]  P. Timms,et al.  Chlamydial Persistence: beyond the Biphasic Paradigm , 2004, Infection and Immunity.

[2]  J. Mahony,et al.  Specimen Processing and Concentration of Chlamydia trachomatis Added Can Influence False-Negative Rates in the LCx Assay but Not in the APTIMA Combo 2 Assay When Testing for Inhibitors , 2003, Journal of Clinical Microbiology.

[3]  A. Nagayama,et al.  Infection of human fibroblast-like synovial cells with Chlamydia trachomatis results in persistent infection and interleukin-6 production. , 2003, Microbial pathogenesis.

[4]  T. Quinn,et al.  Performance of the APTIMA Combo 2 Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Female Urine and Endocervical Swab Specimens , 2003, Journal of Clinical Microbiology.

[5]  A. Nagayama,et al.  Reactivity of a dual amplified chlamydia immunoassay with different serovars of Chlamydia trachomatis , 1999, International journal of STD & AIDS.

[6]  J. Sellors,et al.  Urine Specimens from Pregnant and Nonpregnant Women Inhibitory to Amplification of Chlamydia trachomatis Nucleic Acid by PCR, Ligase Chain Reaction, and Transcription-Mediated Amplification: Identification of Urinary Substances Associated with Inhibition and Removal of Inhibitory Activity , 1998, Journal of Clinical Microbiology.

[7]  K. Ramotar,et al.  Inhibition of PCR in Genital and Urine Specimens Submitted for Chlamydia trachomatis Testing , 1998, Journal of Clinical Microbiology.

[8]  A. Nagayama,et al.  The inhibitory effect of phosphate on the ligase chain reaction used for detecting Chlamydia trachomatis. , 1998, Journal of clinical pathology.

[9]  H. Verbrugh,et al.  Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine , 1997, Journal of clinical microbiology.

[10]  E. Peterson,et al.  Reproducibility problems with the AMPLICOR PCR Chlamydia trachomatis test , 1997, Journal of clinical microbiology.

[11]  P. Thorsen,et al.  Sensitivity of ligase chain reaction assay of urine from pregnant women for Chlamydia trachomatis , 1997, The Lancet.

[12]  H. Verbrugh,et al.  Detection of PCR inhibitors in cervical specimens by using the AMPLICOR Chlamydia trachomatis assay , 1996, Journal of clinical microbiology.

[13]  N. Miyashita,et al.  Evaluation of the sensitivity and specificity of a ligase chain reaction test kit for the detection of Chlamydia trachomatis. , 1996, Journal of clinical pathology.

[14]  B. Dutilh,et al.  Detection of Chlamydia trachomatis by ligase chain reaction compared with polymerase chain reaction and cell culture in urogenital specimens. , 1995, Genitourinary medicine.

[15]  W. Beatty,et al.  Reactivation of persistent Chlamydia trachomatis infection in cell culture , 1995, Infection and immunity.

[16]  W. Beatty,et al.  Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. , 1994, Microbiological reviews.

[17]  W. Stamm,et al.  Diagnosis of Chlamydia trachomatis endocervical infections by a commercial polymerase chain reaction assay , 1993, Journal of clinical microbiology.

[18]  C. A. Bass,et al.  Clinical evaluation of a new polymerase chain reaction assay for detection of Chlamydia trachomatis in endocervical specimens , 1993, Journal of clinical microbiology.

[19]  N. Miyashita,et al.  Establishment of a particle-counting method for purified elementary bodies of chlamydiae and evaluation of sensitivities of the IDEIA Chlamydia kit and DNA probe by using the purified elementary bodies , 1992, Journal of clinical microbiology.

[20]  W. Cates,et al.  Genital chlamydial infections: Epidemiology and reproductive sequelae , 1992 .

[21]  A. Hudson,et al.  Molecular evidence for the presence of chlamydia in the synovium of patients with Reiter's syndrome. , 1992, Arthritis and rheumatism.

[22]  A. Nagayama,et al.  In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis. , 1988, Antimicrobial Agents and Chemotherapy.

[23]  L. Latulippe,et al.  [Reactive arthritis]. , 1980, L'union medicale du Canada.